Co-Diagnostics CODX Stock
Co-Diagnostics Price Chart
Co-Diagnostics CODX Financial and Trading Overview
| Co-Diagnostics stock price | 0.94 USD |
| Previous Close | 1.12 USD |
| Open | 1.14 USD |
| Bid | 0.82 USD x 200 |
| Ask | 1.13 USD x 100 |
| Day's Range | 1.11 - 1.17 USD |
| 52 Week Range | 0.94 - 46.5 USD |
| Volume | 103.52K USD |
| Avg. Volume | 428.01K USD |
| Market Cap | 7.75M USD |
| Beta (5Y Monthly) | 2.855 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -25.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
CODX Valuation Measures
| Enterprise Value | 5.09M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3373494 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.7421875 |
| Price/Book (mrq) | 0.42594016 |
| Enterprise Value/Revenue | 7.055 |
| Enterprise Value/EBITDA | -0.175 |
Trading Information
Co-Diagnostics Stock Price History
| Beta (5Y Monthly) | 2.855 |
| 52-Week Change | -89.51% |
| S&P500 52-Week Change | 15.18% |
| 52 Week High | 46.5 USD |
| 52 Week Low | 0.94 USD |
| 50-Day Moving Average | 1.68 USD |
| 200-Day Moving Average | 3.41 USD |
CODX Share Statistics
| Avg. Volume (3 month) | 428.01K USD |
| Avg. Daily Volume (10-Days) | 116.36K USD |
| Shares Outstanding | 6.98M |
| Float | 6.14M |
| Short Ratio | 0.59 |
| % Held by Insiders | 2.01% |
| % Held by Institutions | 10.53% |
| Shares Short | 214.61K |
| Short % of Float | 3.13% |
| Short % of Shares Outstanding | 3.07% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3732.46% |
| Gross Margin | 43.47% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -59.63% |
| Return on Equity (ttm) | -174.76% |
Income Statement
| Revenue (ttm) | 721.39K USD |
| Revenue Per Share (ttm) | 0.3 USD |
| Quarterly Revenue Growth (yoy) | 2.00% |
| Gross Profit (ttm) | 313.63K USD |
| EBITDA | -29090594 USD |
| Net Income Avi to Common (ttm) | -47056372 USD |
| Diluted EPS (ttm) | -25.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.65M USD |
| Total Cash Per Share (mrq) | 0.58 USD |
| Total Debt (mrq) | 1.8M USD |
| Total Debt/Equity (mrq) | 14.15 USD |
| Current Ratio (mrq) | 1.813 |
| Book Value Per Share (mrq) | 2.606 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27103204 USD |
| Levered Free Cash Flow (ttm) | -17492616 USD |
Profile of Co-Diagnostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2401 S. Foothill Drive |
| ZIP | 84109 |
| Phone | 801 438 1036 |
| Website | https://co-dx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 115 |
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Q&A For Co-Diagnostics Stock
What is a current CODX stock price?
Co-Diagnostics CODX stock price today per share is 0.94 USD.
How to purchase Co-Diagnostics stock?
You can buy CODX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Co-Diagnostics?
The stock symbol or ticker of Co-Diagnostics is CODX.
Which industry does the Co-Diagnostics company belong to?
The Co-Diagnostics industry is Medical Devices.
How many shares does Co-Diagnostics have in circulation?
The max supply of Co-Diagnostics shares is 6.98M.
What is Co-Diagnostics Price to Earnings Ratio (PE Ratio)?
Co-Diagnostics PE Ratio is now.
What was Co-Diagnostics earnings per share over the trailing 12 months (TTM)?
Co-Diagnostics EPS is -25.89 USD over the trailing 12 months.
Which sector does the Co-Diagnostics company belong to?
The Co-Diagnostics sector is Healthcare.
Co-Diagnostics CODX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25978.42 USD — |
-0.01
|
9.18B USD — | 25802.96 USD — | 26225.09 USD — | — - | 9.18B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
133.83 USD — |
-0.1
|
— — | 132.29 USD — | 135.06 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1298.81 USD — |
+0.33
|
— — | 1291.52 USD — | 1308.69 USD — | — - | — — |
- {{ link.label }} {{link}}
